Iliac Stents Market Analysis

Iliac Stents Market Analysis

To get key market trends

  Download Free Sample

Based on type, the market is segmented into self-expandable stents, balloon-expandable stents, and covered stents. The balloon-expandable stents segment is anticipated to witness the fastest growth rate with a CAGR of 5.2% over the forecast period.
 

• Physician preference plays a significant role in device selection and adoption. Some interventional cardiologists and vascular surgeons may prefer balloon-expandable stents due to their familiarity with the deployment technique and perceived ease of use compared to other type of stents, is anticipated to boost the segment expansion.  
   
• Moreover, balloon-expandable stents are often made of durable materials, such as stainless steel or cobalt-chromium alloys, which provide long-term support to the vessel. This durability helps prevent stent collapse or migration over time, reducing the need for repeat interventions and the increase in demand.
   

Based on artery lesions, the iliac stents market is segmented into common iliac artery lesions, severe calcified lesions, and complete obstructive lesions. The common iliac artery lesions segment was valued at USD 563.3 million in 2023.
 

• Risk factors for iliac artery lesions, such as diabetes, obesity, hypertension, and smoking, are becoming more prevalent worldwide. These risk factors accelerate the development and progression of atherosclerosis, which may result in a greater number of individuals requiring treatment for iliac artery lesions.
   
• Moreover, the development of minimally invasive endovascular procedures, such as angioplasty and stenting, has revolutionized the treatment of iliac artery lesions. This increase in the adoption of minimally invasive techniques contributing to the growing demand for interventions targeting iliac artery lesions.  
   

The iliac stents market by end-use is categorized into hospitals, ambulatory surgical centers, and other end-users. The hospital segment dominates the market with the revenue around USD 512.7 million in 2023.
 

• Hospitals typically have specialized departments or units dedicated to interventional cardiology, vascular surgery, or interventional radiology. These departments are staffed with skilled healthcare professionals, including cardiologists, vascular surgeons, and radiologists, who have the expertise to diagnose and treat conditions such as peripheral artery disease (PAD) requiring iliac stenting, making hospitals the primary end user.
   
• Moreover, hospitals, with their access to a wide range of resources, including medical supplies, medications, and support staff, are well-equipped to facilitate the successful execution of iliac stenting procedures. This increased accessibility may position them as the key end users of iliac stents.
   

North America iliac stents market accounted for USD 216.8 million revenue in 2023 and is predicted to witness substantial market growth.
 

• Increasing awareness among patients and healthcare providers about vascular diseases and available treatment options, leading to earlier diagnosis and intervention. Patient education initiatives promote proactive management of vascular conditions, further contributing to the growing demand for iliac stents in North America.
   
• Furthermore, strong clinical evidence supporting the efficacy and safety of iliac stenting, along with clinical practice guidelines recommending endovascular interventions for iliac artery lesions, influence clinical decision-making and drive the demand for these procedures in the region.